Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IceCure Medical (ICCM) FCF Margin (2020 - 2025)

Historic FCF Margin for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to 317.88%.

  • IceCure Medical's FCF Margin rose 1535700.0% to 317.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 460.97%, marking a year-over-year decrease of 1742700.0%. This contributed to the annual value of 379.58% for FY2024, which is 57800.0% down from last year.
  • According to the latest figures from Q3 2025, IceCure Medical's FCF Margin is 317.88%, which was up 1535700.0% from 531.24% recorded in Q2 2025.
  • Over the past 5 years, IceCure Medical's FCF Margin peaked at 123.54% during Q1 2021, and registered a low of 997.25% during Q3 2023.
  • Its 5-year average for FCF Margin is 430.24%, with a median of 446.7% in 2021.
  • As far as peak fluctuations go, IceCure Medical's FCF Margin plummeted by -5207500bps in 2023, and later soared by 5258000bps in 2024.
  • Over the past 5 years, IceCure Medical's FCF Margin (Quarter) stood at 490.03% in 2021, then fell by -26bps to 618.74% in 2022, then soared by 71bps to 177.13% in 2023, then crashed by -170bps to 478.86% in 2024, then skyrocketed by 34bps to 317.88% in 2025.
  • Its FCF Margin was 317.88% in Q3 2025, compared to 531.24% in Q2 2025 and 556.28% in Q1 2025.